{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T16:26:50Z","timestamp":1788798410360,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1016\/j.eururo.2003.11.018","type":"journal-article","created":{"date-parts":[[2003,12,16]],"date-time":"2003-12-16T10:59:24Z","timestamp":1071572364000},"page":"475-482","source":"Crossref","is-referenced-by-count":42,"title":["Pretreatment p53 Nuclear Overexpression as a Prognostic Marker in Superficial Bladder Cancer Treated with Bacillus Calmette\u2013Gu\u00e9rin (BCG)"],"prefix":"10.1016","volume":"45","author":[{"given":"Fabien","family":"Saint","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Aude","family":"Le Frere Belda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Quintela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andras","family":"Hoznek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Jacques","family":"Patard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Bellot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zivko","family":"Popov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie S.","family":"Zafrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude C.","family":"Abbou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique K.","family":"Chopin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sixtina","family":"Gil Diez de Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2003.11.018_BIB1","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0022-5347(17)58737-6","article-title":"Intracavity Bacillus Calmette\u2013Gu\u00e9rin in the treatment of superficial bladder tumors","volume":"116","author":"Morales","year":"1976","journal-title":"J. Urol."},{"key":"10.1016\/j.eururo.2003.11.018_BIB2","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1200\/JCO.1988.6.9.1450","article-title":"Bacillus Calmette\u2013Gu\u00e9rin therapy alters the progression of superficial bladder cancer","volume":"6","author":"Herr","year":"1988","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.eururo.2003.11.018_BIB3","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1464-410X.1995.tb07307.x","article-title":"Analysis of early failures after intravesical instillation therapy with Bacillus Calmette\u2013Gu\u00e9rin for carcinoma in situ of the bladder","volume":"75","author":"Merz","year":"1995","journal-title":"Br. J. Urol."},{"key":"10.1016\/j.eururo.2003.11.018_BIB4","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S0022-5347(05)65756-4","article-title":"Does early cystectomy improve the survival of patients with high risk superficial bladder tumors?","volume":"166","author":"Herr","year":"2001","journal-title":"J. Urol."},{"key":"10.1016\/j.eururo.2003.11.018_BIB5","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1046\/j.1464-4096.2001.001020.x","article-title":"Outcome of radical cystectomy for bladder cancer according to the disease type at presentation","volume":"89","author":"Yiou","year":"2002","journal-title":"BJU Int."},{"key":"10.1016\/j.eururo.2003.11.018_BIB6","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0046-8177(98)90225-8","article-title":"The prevalence of bcl-2, p53, and Ki-67 immunoreactivity in transitional cell bladder carcinoma and their clinicopathologic correlates","volume":"29","author":"Nakopoulou","year":"1998","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.eururo.2003.11.018_BIB7","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8<1472::AID-CNCR15>3.0.CO;2-2","article-title":"The prognostic value of p53 nuclear overexpression and MIB-1 as a proliferative marker in transitional cell carcinoma of the bladder","volume":"80","author":"Popov","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2003.11.018_BIB8","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/S0022-5347(01)64825-0","article-title":"Long-term efficacy of intravesical Bacillus Calmette\u2013Gu\u00e9rin for carcinoma in situ: relationship of progression to histological response and p53 nuclear accumulation","volume":"157","author":"Ovesen","year":"1997","journal-title":"J. Urol."},{"key":"10.1016\/j.eururo.2003.11.018_BIB9","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S0022-5347(01)63731-5","article-title":"Correlation between p53 over expression and response to Bacillus Calmette\u2013Gu\u00e9rin therapy in a high risk select population of patients with T1G3 bladder cancer","volume":"159","author":"Lebret","year":"1998","journal-title":"J. Urol."},{"key":"10.1016\/j.eururo.2003.11.018_BIB10","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0022-5347(01)61770-1","article-title":"Correlation and prognostic significance of p53, p21WAF1\/CIP1 and Ki-67 expression in patients with superficial bladder tumors treated with Bacillus Calmette\u2013Gu\u00e9rin intravesical therapy","volume":"161","author":"Zlotta","year":"1999","journal-title":"J. Urol."},{"key":"10.1016\/j.eururo.2003.11.018_BIB11","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0090-4295(01)01551-5","article-title":"Prognostic value of p53 overexpression in T1G3 bladder tumors treated with Bacilus Calmette\u2013Gu\u00e9rin therapy","volume":"59","author":"Peyromaure","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2003.11.018_BIB12","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0022-5347(01)63839-4","article-title":"p53 status does not predict initial clinical response to Bacillus Calmette\u2013Gu\u00e9rin intravesical therapy in T1 bladder tumors","volume":"159","author":"Pages","year":"1998","journal-title":"J. Urol."},{"key":"10.1016\/j.eururo.2003.11.018_BIB13","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1093\/jnci\/88.15.1054","article-title":"Loss of tumor marker-immunostaining intensity on stored paraffin slides of breast cancer","volume":"88","author":"Jacobs","year":"1996","journal-title":"J. Natl. Cancer. Inst."},{"key":"10.1016\/j.eururo.2003.11.018_BIB14","unstructured":"Sobin LH, Wittekind Ch, editors. UICC\/TNM Classification of malignant tumours. 5th ed. New York: John Wiley; 1997."},{"key":"10.1016\/j.eururo.2003.11.018_BIB15","unstructured":"Mostofi FK, Sobin LH, Torloni H. Histological typing of urinary bladder tumours. International histological classification of tumours, N\u00b010. Geneva: World Health Organization; 1973."},{"key":"10.1016\/j.eururo.2003.11.018_BIB16","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1200\/JCO.1996.14.10.2646","article-title":"Overexpression of p53 protein in a high-risk population of patients with superficial bladder cancer before and after Bacillus Calmette\u2013Gu\u00e9rin therapy: correlation to clinical outcome","volume":"14","author":"Lacombe","year":"1996","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.eururo.2003.11.018_BIB17","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/biomet\/62.2.269","article-title":"Partial likelihood","volume":"62","author":"Cox","year":"1975","journal-title":"Biometrika"},{"key":"10.1016\/j.eururo.2003.11.018_BIB18","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/351453a0","article-title":"The p53 tumour suppressor gene","volume":"351","author":"Levine","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.eururo.2003.11.018_BIB19","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/S0090-4295(01)00968-2","article-title":"p53 in bladder cancer: mechanism of action, prognostic value, and target for therapy","volume":"57","author":"Slaton","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2003.11.018_BIB20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1096-9896(199609)180:1<1::AID-PATH712>3.3.CO;2-L","article-title":"p53 integrating the complexity","volume":"180","author":"Hall","year":"1996","journal-title":"J. Pathol."},{"key":"10.1016\/j.eururo.2003.11.018_BIB21","first-page":"1015","article-title":"Recombinant adenovirus expressing wild-type p53 is antiangiogenic: a proposed mechanisms for bystander effect","volume":"5","author":"Nishizaki","year":"1999","journal-title":"Clin. Cancer. Res."},{"key":"10.1016\/j.eururo.2003.11.018_BIB22","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/(SICI)1097-0142(19980215)82:4<715::AID-CNCR15>3.0.CO;2-0","article-title":"Invasion of the bladder by transitional cell carcinoma: its relation to histologic grade and expression of p53, MIB-1, c-erb B-2, Epidermal Growth Factor Receptor, and bcl-2","volume":"82","author":"Vollmer","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2003.11.018_BIB23","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/S0022-5347(05)68347-4","article-title":"Immunohistochemical detection of p53 protein overexpression versus gene sequencing in urinary bladder carcinoma","volume":"162","author":"Bernardini","year":"1999","journal-title":"J. Urol."},{"key":"10.1016\/j.eururo.2003.11.018_BIB24","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/bjc.1995.41","article-title":"p53 immunohistochemistry as an independent prognostic factor for superficial transitional cell carcinoma of the bladder","volume":"71","author":"Serth","year":"1995","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.eururo.2003.11.018_BIB25","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1159\/000020232","article-title":"p53 expression predicts progression and poor survival in T1 bladder tumours","volume":"37","author":"Llopis","year":"2000","journal-title":"Eur. Urol."},{"key":"10.1016\/j.eururo.2003.11.018_BIB26","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0959-8049(99)00325-1","article-title":"p53 immunoreactivity in biopsy specimens of T1G3 transitional cell carcinoma of the bladder: a helpful parameter in guiding the decision for or against cystectomy?","volume":"36","author":"Steiner","year":"2000","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.eururo.2003.11.018_BIB27","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1159\/000050635","article-title":"Prognostic value of p53, p21\/WAF1, Bcl-2, Bax, Bak, and Ki-67 immunoreactivity in pT1G3 urothelial bladder carcinomas","volume":"22","author":"Wolf","year":"2001","journal-title":"Tumor. Biol."},{"key":"10.1016\/j.eururo.2003.11.018_BIB28","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1159\/000020039","article-title":"Prognostic value of MIB-1 score p53, EGFr, mitotic index and papillary status in primary superficial (stage pTa\/T1) bladder cancer: a prospective comparative study. The finnbladder group","volume":"36","author":"Liukkonen","year":"1999","journal-title":"Eur. Urol."},{"key":"10.1016\/j.eururo.2003.11.018_BIB29","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S0022-5347(05)67798-1","article-title":"The role of BCL-2, p53, and KI-67 index in predicting tumor recurrence for low grade superficial transitional cell bladder carcinoma","volume":"163","author":"Wu","year":"2000","journal-title":"J. Urol."},{"key":"10.1016\/j.eururo.2003.11.018_BIB30","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/00005392-200101000-00011","article-title":"The predictive value of muscularis mucosae invasion and p53 over expression on progression of stage T1 bladder carcinoma","volume":"165","author":"Bernardini","year":"2001","journal-title":"J. Urol."},{"key":"10.1016\/j.eururo.2003.11.018_BIB31","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00005392-199907000-00017","article-title":"P53 mutations in bladder tumors inactivate the transactivation of the P21 and BAX genes, and have a predictive value for the clinical outcome after Bacillus Calmette\u2013Gu\u00e9rin","volume":"162","author":"Pfister","year":"1999","journal-title":"J. Urol."},{"key":"10.1016\/j.eururo.2003.11.018_BIB32","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0090-4295(96)00624-3","article-title":"Significance of p53 overexpression in urinary bladder transitional cell carcinoma in situ before and after Bacillus Calmette\u2013Gu\u00e9rin treatment","volume":"49","author":"Ick","year":"1997","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2003.11.018_BIB33","first-page":"274","article-title":"Improved antigen retrieval in formalin-fixed, paraffin-embedded tissues","volume":"2","author":"Beckstead","year":"1994","journal-title":"Appl. Immunohistochem."},{"key":"10.1016\/j.eururo.2003.11.018_BIB34","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/jnci\/88.15.1015","article-title":"Loss of p53-immunostaining intensity in breast cancer [Editorial]","volume":"88","author":"Henson","year":"1996","journal-title":"J. Natl. Cancer. Inst."},{"key":"10.1016\/j.eururo.2003.11.018_BIB35","first-page":"1854","article-title":"Reproducibility of p53 immunohistochemistry in bladder tumors","volume":"6","author":"McShane","year":"2000","journal-title":"Clin. Cancer. Res."},{"key":"10.1016\/j.eururo.2003.11.018_BIB36","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/jnci\/88.3-4.173","article-title":"The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry","volume":"88","author":"Sjogren","year":"1996","journal-title":"J. Natl. Cancer. Inst."},{"key":"10.1016\/j.eururo.2003.11.018_BIB37","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2307\/2530613","article-title":"An improved approximate formula for calculating sample sizes for comparing two binomial distributions","volume":"34","author":"Casagrande","year":"1978","journal-title":"Biometrics"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283803005906?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283803005906?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,16]],"date-time":"2019-02-16T05:24:23Z","timestamp":1550294663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283803005906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["S0302283803005906"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2003.11.018","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2004,4]]}}}